AU2001283985A1 - Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type - Google Patents

Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type

Info

Publication number
AU2001283985A1
AU2001283985A1 AU2001283985A AU8398501A AU2001283985A1 AU 2001283985 A1 AU2001283985 A1 AU 2001283985A1 AU 2001283985 A AU2001283985 A AU 2001283985A AU 8398501 A AU8398501 A AU 8398501A AU 2001283985 A1 AU2001283985 A1 AU 2001283985A1
Authority
AU
Australia
Prior art keywords
type
peptide sequences
specifically cleaved
identifying peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283985A
Inventor
Frank Ploger
Ralph Reimholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phylos Inc
Original Assignee
Xzillion GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xzillion GmbH and Co KG filed Critical Xzillion GmbH and Co KG
Publication of AU2001283985A1 publication Critical patent/AU2001283985A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6818—Sequencing of polypeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
AU2001283985A 2000-08-22 2001-08-07 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type Abandoned AU2001283985A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10041238A DE10041238A1 (en) 2000-08-22 2000-08-22 Process for the identification of specifically cleavable peptides and use of such peptide sequences
DE10041238 2000-08-22
PCT/EP2001/009102 WO2002016574A2 (en) 2000-08-22 2001-08-07 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type

Publications (1)

Publication Number Publication Date
AU2001283985A1 true AU2001283985A1 (en) 2002-03-04

Family

ID=7653429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283985A Abandoned AU2001283985A1 (en) 2000-08-22 2001-08-07 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type

Country Status (6)

Country Link
EP (1) EP1314039A2 (en)
JP (1) JP2004507240A (en)
AU (1) AU2001283985A1 (en)
CA (1) CA2420065A1 (en)
DE (1) DE10041238A1 (en)
WO (1) WO2002016574A2 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361943B1 (en) * 1996-10-17 2002-03-26 Mitsubishi Chemical Corporation Molecule that homologizes genotype and phenotype and utilization thereof
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
AU5827294A (en) * 1992-12-11 1994-07-04 Chiron Corporation Synthesis of encoded polymers
DE4344919A1 (en) * 1993-12-30 1995-07-06 Behringwerke Ag Procedure for determining platelet aggregation
US6803188B1 (en) * 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
EP0959894B1 (en) * 1996-06-10 2004-10-13 The Scripps Research Institute Use of substrate subtraction libraries to distinguish enzyme specificities
PT971946E (en) * 1997-01-21 2006-11-30 Gen Hospital Corp Selection of proteins using rna-protein fusions
JP4451518B2 (en) * 1999-10-06 2010-04-14 康則 北本 Hybrid cell, monoclonal antibody, production method and measurement method
CA2401155A1 (en) * 2000-04-05 2001-10-11 Alcide Barberis Method for identify polypeptides with protease activity

Also Published As

Publication number Publication date
EP1314039A2 (en) 2003-05-28
WO2002016574A2 (en) 2002-02-28
DE10041238A1 (en) 2002-03-07
JP2004507240A (en) 2004-03-11
WO2002016574A3 (en) 2002-09-06
CA2420065A1 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
IL153970A0 (en) Promyostatin peptides and methods of using same
AU2001286730A1 (en) An iap binding peptide or polypeptide and methods of using the same
AU2003267124A1 (en) Bh3 peptides and method of use thereof
AU2001236638A1 (en) Evi27 gene sequences and protein encoded thereby
AU2002338428A1 (en) Methods and systems for identifying proteins
IL145850A0 (en) Adhesion modulatory peptides and methods for use
AU2002218269A1 (en) Proteins and dna sequences underlying these proteins used for treating inflammations
AU2002225247A1 (en) The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
AU2002227279A1 (en) Polynucleotide and polypeptide sequences of putative transporters and ion channells
AU7847400A (en) Method for determining and modifying protein/peptide solubility
AU2002249984A1 (en) Peptide or protein microassay method and apparatus
IL138946A0 (en) Method for the identification of peptides and proteins
AU2002345287A1 (en) Peptide and protein identification method
AU2001288390A1 (en) Proteins and nucleic acids encoding same
AU4229599A (en) Protease inhibitor peptides
AU2001278655A1 (en) Novel nucleic acid and amino acid sequences
AU2002339715A1 (en) Synthetic peptides and dna sequences for treatment of multiple sclerosis
IL154357A0 (en) Stress proteins and peptides and methods of use thereof
AU6975001A (en) Metalloprotease peptide substrates and methods
AU3207799A (en) Mpr-related abc transporter encoding nucleic acids and methods of use thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001283985A1 (en) Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
AU2002365084A1 (en) Method and reagent for the detection of proteins and peptides
AU2002213954A1 (en) Method for the selective modification of peptides and proteins
AU7275900A (en) Method for determining nucleic and/or amino acid sequences